mobile btn
Monday, February 6th, 2023

Public Health

Legislation targets fentanyl smugglers

U.S. Reps. Brian Fitzpatrick (R-PA), Tim Burchett (R-TN), Tom Tiffany (R-WI), and Michael Guest (R-MS) recently introduced a measure they said would ensure fentanyl smuggler accountability for their role in the nation's opioid epidemic. The Fentanyl Trafficker Elimination Act seeks to increase... Read More »

MilliporeSigma secures DoD, HHS agreement

MilliporeSigma, based in Sheboygan, Wis., has secured a Department of Defense (DoD) and Department of Health and Human Services (HHS) pact to establish domestic nitrocellulose membrane production capacity. The $136.7 million contract would enable MilliporeSigma to expand its industrial base to... Read More »

AstraZeneca COVID-19 antibodies garner FDA approval

The U.S. Food and Drug Administration (FDA) approved this week an emergency use authorization (EUA) for AstraZeneca’s Evusheld, authorizing the use of monoclonal antibodies to reduce specific COVID-19 risk. Evusheld is tixagevimab co-packaged with cilgavimab and administered together to... Read More »

DHS releases synthetic opioids reference guide

The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has released a new Master Question List (MQL) for Synthetic Opioids. The MQL serves as a reference guide as a means of aiding emergency responders and the research community by providing critical and vetted... Read More »